These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5045595)

  • 1. Glucagon in the treatment of ouabain-induced cardiac arrhythmias in dogs.
    Prasad K; Desousa HH
    Cardiovasc Res; 1972 Jul; 6(4):333-43. PubMed ID: 5045595
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon-induced cardiac effects following normal and toxic doses of ouabain.
    Denney DL; Daniell HB
    Arch Int Pharmacodyn Ther; 1971 May; 191(1):111-9. PubMed ID: 5557388
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of potassium canrenoate to suppress ouabain-induced ventricular arrhythmias in dogs.
    Yeh BK; Sung PK; Saha AK
    Circ Res; 1972 Dec; 31(6):915-22. PubMed ID: 4641788
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of glucagon on arrhythmias due to digitalis toxicity.
    Cohn KE; Agmon J; Gamble OW
    Am J Cardiol; 1970 Jun; 25(6):683-9. PubMed ID: 4192693
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
    Sano N; Kawada M; Fukutomi Y
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of ouabain on the arrhythmic effect of catecholamines].
    Mukaoara K
    Nihon Yakurigaku Zasshi; 1970; 66(1):36-44. PubMed ID: 4393358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide].
    Igarashi T; Hashimoto N
    Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of halothane on ventricular automaticity.
    Logic JR; Morrow DH
    Anesthesiology; 1972 Feb; 36(2):107-11. PubMed ID: 5059098
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated cardiac escape rhythms caused by ouabain intoxication.
    Zipes DP; Arbel E; Knope RF; Moe GK
    Am J Cardiol; 1974 Feb; 33(2):248-53. PubMed ID: 4129551
    [No Abstract]   [Full Text] [Related]  

  • 11. Ability of glucagon to produce cardiac stimulation without arrhythmias in halothane-anaesthetized animals.
    Katz RL; Hinds L; Mills CJ
    Br J Anaesth; 1969 Jul; 41(7):574-8. PubMed ID: 5798835
    [No Abstract]   [Full Text] [Related]  

  • 12. Central beta-adrenoceptor sites and ouabain action.
    Saxena PR; Bhargava KP
    Pharmacol Res Commun; 1974 Aug; 6(4):347-55. PubMed ID: 4373769
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracerebroventricular l-hyoscyamine, ethybenztropine and procaine on cardiac arrhythmias induced in dogs by pentylenetetrazol, picrotoxin or deslanoside.
    Rozear M; Bircher RP; Chai CY; Wang SC
    Int J Neuropharmacol; 1968 Jan; 7(1):1-6. PubMed ID: 5639304
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenergic contribution to digitalis action.
    Tanabe T; Shudo I; Saito H
    Proc West Pharmacol Soc; 1975; 18():20-2. PubMed ID: 241087
    [No Abstract]   [Full Text] [Related]  

  • 16. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of microinjections of ouabain into certain medullary areas in cats.
    Basu-Ray BN; Dutta SN; Pradhan SN
    J Pharmacol Exp Ther; 1972 May; 181(2):357-61. PubMed ID: 4555430
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiotoxic interactions between sympathomimetic amines and ouabain.
    Lum BK; Yano SS; Yatsushiro GN
    Proc West Pharmacol Soc; 1977; 20():275-80. PubMed ID: 896835
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 20. Vagal tuning for the control of supraventricular arrhythmias.
    Bilgutay AM; Bilgutay IM; Lillehei CW
    Surg Forum; 1965; 16():151-3. PubMed ID: 5835127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.